The two single-nucleotide polymorphisms (SNPs), rs17026688 and rs17026651, and the GADL1 variant IVS8 + 48delG are useful markers to predict the response to lithium treatment of patients of Asian descent who have bipolar I disorder. Here, GADL1 is linked to bipolar I disorder.